Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature ; day:28 ; month:9 ; year:2023 ; pages:1-9
Current rheumatology reports ; (28.9.2023), 1-9
- Creator
-
Vermeer, Eva
Hebing, Renske C. F.
Meeberg, Maartje M. van de
Lin, Marry
Meij, Tim G. J. de
Struys, Eduard A.
Jansen, Gerrit
Nurmohamed, Michael T.
Ćalasan, Maja Bulatović
Jonge, Robert de
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11926-023-01116-7
- URN
-
urn:nbn:de:101:1-2023121515571781076390
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vermeer, Eva
- Hebing, Renske C. F.
- Meeberg, Maartje M. van de
- Lin, Marry
- Meij, Tim G. J. de
- Struys, Eduard A.
- Jansen, Gerrit
- Nurmohamed, Michael T.
- Ćalasan, Maja Bulatović
- Jonge, Robert de
- SpringerLink (Online service)
Other Objects (12)
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Procedural pain and patient-reported side effects with weekly injections of subcutaneous Methotrexate in children with rheumatic disorders
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
Maintenance therapy with subcutaneous immunoglobulin in a patient with immune‐mediated neuropathic postural tachycardia syndrome
Neurodevelopmental disorders: 2021 update
Neurodevelopmental disorders: 2023 update
Neurodevelopmental disorders: 2024 update
Neurodevelopmental disorders: 2022 update
Early Development of the Gut Microbiome and Immune-Mediated Childhood Disorders
Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Procedural pain and patient-reported side effects with weekly injections of subcutaneous Methotrexate in children with rheumatic disorders
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
Maintenance therapy with subcutaneous immunoglobulin in a patient with immune‐mediated neuropathic postural tachycardia syndrome
Neurodevelopmental disorders: 2021 update
Neurodevelopmental disorders: 2023 update
Neurodevelopmental disorders: 2024 update
Neurodevelopmental disorders: 2022 update
Early Development of the Gut Microbiome and Immune-Mediated Childhood Disorders
Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Procedural pain and patient-reported side effects with weekly injections of subcutaneous Methotrexate in children with rheumatic disorders
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
Maintenance therapy with subcutaneous immunoglobulin in a patient with immune‐mediated neuropathic postural tachycardia syndrome
Neurodevelopmental disorders: 2021 update
Neurodevelopmental disorders: 2023 update
Neurodevelopmental disorders: 2024 update
Neurodevelopmental disorders: 2022 update
Early Development of the Gut Microbiome and Immune-Mediated Childhood Disorders